Literature DB >> 21273510

Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.

Catherine Uzan1, Aminata Kane, Annie Rey, Sebastien Gouy, Sophie Camatte, Patricia Pautier, Catherine Lhommé, Christine Haie-Meder, Pierre Duvillard, Philippe Morice.   

Abstract

BACKGROUND: To determine the prognosis of a micropapillary (MP) pattern in patients with stage II and stage III serous borderline tumor of the ovary (SBOT).
METHODS: Review of patients with stage II and stage III SBOT treated or referred to our institution with characterization of an MP pattern and its clinical impact.
RESULTS: In 1969-2006, 168 patients were reviewed. Fifty-six patients had SBOT-MP. The rate of conservative surgery was lower in the SBOT-MP group than in the typical SBOT group, but the rate of patients with more than three peritoneal sites with implants was higher in the SBOT-MP group. The rate of invasive implants was not statistically different between the two groups. Eighteen recurrences were observed (six of them in the form of invasive disease) in the SBOT-MP group. Only one death was observed. The overall survival times and recurrence-free intervals were similar in both groups. The only prognostic factor for recurrence in the SBOT-MP group was the use of conservative surgery.
CONCLUSIONS: In the present series, an MP pattern doesn't appear to signify a poor prognosis. The only prognostic factor for recurrence in SBOT-MP was the use of conservative surgery. Further studies on the MP pattern are needed to evaluate prognosis and the results of conservative surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21273510      PMCID: PMC3228092          DOI: 10.1634/theoncologist.2009-0139

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  18 in total

1.  Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  1987-01       Impact factor: 8.661

2.  Serous tumors of the ovary (borderline tumors and carcinomas) with and without micropapillary features.

Authors:  Jaime Prat
Journal:  Int J Gynecol Pathol       Date:  2003-01       Impact factor: 2.762

3.  Is micropapillary serous carcinoma for real?

Authors:  David M Gershenson
Journal:  Cancer       Date:  2002-08-15       Impact factor: 6.860

4.  Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.

Authors:  Isabelle Laurent; Catherine Uzan; Sebastien Gouy; Patricia Pautier; Pierre Duvillard; Philippe Morice
Journal:  Ann Surg Oncol       Date:  2008-09-27       Impact factor: 5.344

5.  Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis.

Authors:  D A Bell; M A Weinstock; R E Scully
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

6.  Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases.

Authors:  C Blake Gilks; Abdulmohsen Alkushi; Jenice J W Yue; Dominique Lanvin; Thomas G Ehlen; Dianne M Miller
Journal:  Int J Gynecol Pathol       Date:  2003-01       Impact factor: 2.762

7.  Impact of surgical staging in patients with macroscopic "stage I" ovarian borderline tumours: analysis of a continuous series of 101 cases.

Authors:  Sophie Camatte; Philippe Morice; Anne Thoury; Virgine Fourchotte; Patricia Pautier; Catherine Lhomme; Pierre Duvillard; Damienne Castaigne
Journal:  Eur J Cancer       Date:  2004-08       Impact factor: 9.162

8.  Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.

Authors:  Ann E Smith Sehdev; Paul S Sehdev; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

9.  Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.

Authors:  Jaime Prat; Michele De Nictolis
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

10.  Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases.

Authors:  Michael T Deavers; David M Gershenson; Guillermo Tortolero-Luna; Anais Malpica; Karen H Lu; Elvio G Silva
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

View more
  9 in total

1.  Micropapillary pattern in newly diagnosed borderline tumors of the ovary: what's in a name?

Authors:  Mario M Leitao
Journal:  Oncologist       Date:  2011-01-27

2.  Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 Cases.

Authors:  Russell Vang; Charlotte G Hannibal; Jette Junge; Kirsten Frederiksen; Susanne K Kjaer; Robert J Kurman
Journal:  Am J Surg Pathol       Date:  2017-06       Impact factor: 6.394

3.  A nationwide study of serous "borderline" ovarian tumors in Denmark 1978-2002: centralized pathology review and overall survival compared with the general population.

Authors:  Charlotte Gerd Hannibal; Russell Vang; Jette Junge; Kirsten Frederiksen; Anette Kjaerbye-Thygesen; Klaus Kaae Andersen; Ann Tabor; Robert J Kurman; Susanne K Kjaer
Journal:  Gynecol Oncol       Date:  2014-06-10       Impact factor: 5.482

4.  A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.

Authors:  Charlotte Gerd Hannibal; Russell Vang; Jette Junge; Kirsten Frederiksen; Robert J Kurman; Susanne K Kjaer
Journal:  Gynecol Oncol       Date:  2016-11-09       Impact factor: 5.482

Review 5.  Fertility sparing treatment in borderline ovarian tumours.

Authors:  Rosa Maria Alvarez; Daniel Vazquez-Vicente
Journal:  Ecancermedicalscience       Date:  2015-02-03

6.  Serous borderline tumor with micropapillary pattern of the right ovary that developed 6 recurrences over 30 years after primary surgery.

Authors:  Mari Minagawa; Mamoru Maeda; Masahito Shimauchi; Hirohisa Kishi; Shinichi Teshima
Journal:  Gynecol Oncol Rep       Date:  2018-05-31

7.  Risk Factors for Recurrence of Borderline Ovarian Tumours after Conservative Surgery and Impact on Fertility: A Multicentre Study by the Francogyn Group.

Authors:  Adele Ozenne; Marion De Berti; Gilles Body; Xavier Carcopino; Olivier Graesslin; Yohan Kerbage; Cherif Akladios; Cyrille Huchon; Alexandre Bricou; Camille Mimoun; Emilie Raimond; Lobna Ouldamer
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

8.  Prognosis and Prognostic Factors of Serous Borderline Tumor-Micropapillary Variant: Retrospective Study of 200 Patients with Long-Term Follow-Up.

Authors:  Shuang-Zheng Jia; Hong-Wen Yao; Ning Li; Jun-Jun Yang; Yang Xiang; Shan Zheng; Jin-Hua Leng; Ling-Ying Wu
Journal:  J Oncol       Date:  2022-10-10       Impact factor: 4.501

9.  External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours.

Authors:  S Bendifallah; C Uzan; R Fauvet; P Morice; E Darai
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.